Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Clearmind's MEAI shows suppressive effect on alcohol consumption in mice

May 20, 2022

Novel selective D3R ligands for the treatment of drug addiction

May 19, 2022

M1 mAChR antagonism attenuates opioid drug seeking behaviors in rat

May 5, 2022

CNRS and collaborators patent acetylcholinesterase reactivators

April 1, 2022

Red Bull GmbH presents dopamine reuptake inhibitors

Jan. 20, 2022

Metabotropic glutamate mGlu2 receptor found to be associated with alcoholism

Nov. 30, 2021

Researchers develop a rat model of oxycodone/cocaine withdrawal syndrome

Nov. 23, 2021

One-year challenge data from preclinical study of ATI-1701 in lethal model of tularemia

Nov. 22, 2021

New and known compounds targeting PTPRD may treat AD, addiction and restless legs syndrome

Nov. 4, 2021

New treatment targets identified in opiate abstinence

Nov. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...